Stay updated on INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Sign up to get notified when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.
Latest updates to the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page
- Check2 days agoChange DetectedAdditions include two literature references and a revision notice, while deletions remove the corresponding errata and an earlier revision note; these changes affect bibliographic context but do not modify study design, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check9 days agoChange DetectedShow glossary toggle added; study record metadata updated to Revision 3.4.0 with QC fields adjusted (Last Update Submitted that Met QC Criteria and No FEAR Act Data). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check17 days agoChange DetectedPublication section updated with a new PubMed citation for the urelumab + nivolumab study and an auto-fill note indicating PubMed as the data source. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check24 days agoChange DetectedRevision: v3.3.4 was published replacing v3.3.3; no study content or essential features were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check31 days agoChange DetectedTwo new citations were added and two existing citations were removed in the Publications section, resulting in a net-neutral update to the study's references. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check45 days agoChange DetectedDifference0.2%
Stay in the know with updates to INTRUST: Urelumab/Nivolumab Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.